v3.23.1
Equity-based compensation (Tables)
12 Months Ended
Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of stock based compensation by type of award The following table sets forth stock-based compensation by type of award:
For the fiscal years ended
January 31,
 202320222021
RSUs$42,214 $24,222 $10,693 
Liability awards7,641 7,055 — 
PSUs7,282 2,389 93 
Stock options1,489 2,294 2,703 
ESPP1,521 763 — 
Total stock-based compensation$60,147 $36,723 $13,489 
Schedule of stock based compensation in financial statements
The following table sets forth the presentation of stock-based compensation in the Company's financial statements:


For the fiscal years ended
January 31,
 202320222021
Stock-based compensation expense recorded to additional paid-in capital(1)
$52,506 $29,668 $13,489 
Stock-based compensation expense recorded to accrued expenses7,641 7,055 — 
Total stock-based compensation60,147 36,723 13,489 
Less stock-based compensation expense capitalized as internal-use software(1,372)(489)— 
Stock-based compensation expense per consolidated statements of operations(2)
$58,775 $36,234 $13,489 
(1) Stock-based compensation included in the Company's consolidated statements of stockholders' equity is consistent with these amounts.
(2) Non-cash stock-based compensation expense included in the Company's consolidated statement of cash flows for the fiscal year ended January 31, 2022 was $36,144, and excluded $90 of cash-settled stock-based compensation expense included in the Company's statements of operations.
Schedule of restricted stock unit activity
  Restricted stock units
Unvested, January 31, 20201,447,418 
Granted during year
972,271 
Vested(242,049)
Forfeited and expired(124,602)
Unvested, January 31, 20212,053,038 
Granted during year
1,836,534 
Vested(559,767)
Forfeited and expired(195,966)
Unvested, January 31, 20223,133,839 
Granted during year
2,907,838 
Vested(1,626,679)
Forfeited and expired (497,245)
Unvested, January 31, 2023
3,917,753 
Schedule of stock option activity Stock option activity for the fiscal years ended January 31, 2023, 2022 and 2021 is as follows:
Number of
options
Weighted-
average
exercise price
Weighted-
average
remaining
contractual life
(in years)
Aggregate Intrinsic
value
Outstanding—January 31, 20205,516,452 $3.80 
Granted during the year— $— 
Exercised(2,216,368)$2.39 
Forfeited(88,730)$7.45 
Outstanding and expected to vest — January 31, 2021
3,211,354 $4.67 5.99$194,676 
Outstanding—January 31, 20213,211,354 $4.67 
Granted during the year— $— 
Exercised(1,439,186)$2.88 
Forfeited and expired(67,018)$9.02 
Outstanding and expected to vest — January 31, 2022
1,705,150 $6.01 5.94$42,938 
Outstanding—January 31, 20221,705,150 $6.01 
Granted during the year— $— 
Exercised(311,743)$4.92 
Forfeited and expired(8,214)$4.68 
Outstanding and expected to vest — January 31, 2023
1,385,193 $6.26 5.06$43,341 
Exercisable — January 31, 2023
1,362,903 $6.12 5.03$42,750 
Amount vested during year ended January 31, 2023
258,735 $8.27 
Schedule of measurement inputs and valuation techniques The fair value of the PSUs granted during the fiscal years ended January 31, 2023, 2022 and 2021, respectively, was estimated using the following assumptions:
Fiscal years ended
January 31,
 202320222021
Correlation coefficient0.4957 0.3878 0.4230 
Valuation date stock price$35.41 $36.03 $62.96 
Simulation term3.00 Years2.99 Years3.00 Years
Volatility64.98 %44.32 %43.71 %
Risk-free rate3.84 %1.23 %0.20 %
Dividend yield— %— %— %
Weighted average fair value of grants
$56.52 $48.47 $84.38 
Schedule of market-based performance stock unit activity Market based PSU activity for the years ended January 31, 2023, 2022 and 2021 are as follows:
Performance
stock units
Outstanding February 1, 2020— 
Granted during the year ended January 31, 202170,806 
Outstanding, February 1, 202170,806 
Granted during the year ended January 31, 2022325,410 
Vested— 
Forfeited and expired— 
Outstanding, February 1, 2022396,216 
Granted during the year ended January 31, 2023
255,572 
Vested— 
Forfeited and expired(3,555)
Outstanding, January 31, 2023
648,233 
Schedule of ESPP valuation assumptions The fair value of shares granted under the ESPP during the year ended January 31, 2023 was estimated using a Black-Scholes pricing model with the following assumptions:
Year ended
January 31, 2023
Year ended
January 31, 2022
Risk-free interest rate
3.68 %0.17 %
Expected dividends
nonenone
Expected term (in years)
0.47 years0.49 years
Volatility
74.8 %55.7 %